COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFECTIONS IN CANINE AND FELINE ANIMALS
Compositions and methods for treating or preventing infections in canine or feline animals which comprises administering an effective amount of granulocyte colony stimulating factor (G-CSF), are disclosed. The G-CSF may be naturally derived, or alternatively, the G-CSF and genetically engineered var...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BOONE, THOMAS, C MILLER, ALLAN, L |
| description | Compositions and methods for treating or preventing infections in canine or feline animals which comprises administering an effective amount of granulocyte colony stimulating factor (G-CSF), are disclosed. The G-CSF may be naturally derived, or alternatively, the G-CSF and genetically engineered variance of G-CSF may be the expression products of genetically engineered prokaryotic or eukaryotic host cells.
Compositions et procédés de traitement ou de prévention d'infections chez les animaux canins ou félins, consistant à administrer une dose efficace de facteur de croissance des colonies de granulocytes (FCCG). Le FCCG peut être dérivé naturellement, ou selon un autre mode de réalisation, le FCCG ainsi que des variantes de celui-ci mises au point génétiquement peuvent être les produits d'expression de cellules hôtes procaryotiques ou eucaryotiques mises au point génétiquement. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO9105798A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO9105798A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO9105798A13</originalsourceid><addsrcrecordid>eNrjZIh29vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUggJcnUM8fRzVwCyA4Jcw1z9wDxPPzdXZ4gOTz8FZ0c_Tz9XsF43Vx8I09PX0SeYh4E1LTGnOJUXSnMzABWEOHvophbkx6cWFyQmp-allsSH-1saGpiaW1o4GhoToQQAMQMx0g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFECTIONS IN CANINE AND FELINE ANIMALS</title><source>esp@cenet</source><creator>BOONE, THOMAS, C ; MILLER, ALLAN, L</creator><creatorcontrib>BOONE, THOMAS, C ; MILLER, ALLAN, L</creatorcontrib><description>Compositions and methods for treating or preventing infections in canine or feline animals which comprises administering an effective amount of granulocyte colony stimulating factor (G-CSF), are disclosed. The G-CSF may be naturally derived, or alternatively, the G-CSF and genetically engineered variance of G-CSF may be the expression products of genetically engineered prokaryotic or eukaryotic host cells.
Compositions et procédés de traitement ou de prévention d'infections chez les animaux canins ou félins, consistant à administrer une dose efficace de facteur de croissance des colonies de granulocytes (FCCG). Le FCCG peut être dérivé naturellement, ou selon un autre mode de réalisation, le FCCG ainsi que des variantes de celui-ci mises au point génétiquement peuvent être les produits d'expression de cellules hôtes procaryotiques ou eucaryotiques mises au point génétiquement.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES USING MICROORGANISMS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>1991</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19910502&DB=EPODOC&CC=WO&NR=9105798A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19910502&DB=EPODOC&CC=WO&NR=9105798A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BOONE, THOMAS, C</creatorcontrib><creatorcontrib>MILLER, ALLAN, L</creatorcontrib><title>COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFECTIONS IN CANINE AND FELINE ANIMALS</title><description>Compositions and methods for treating or preventing infections in canine or feline animals which comprises administering an effective amount of granulocyte colony stimulating factor (G-CSF), are disclosed. The G-CSF may be naturally derived, or alternatively, the G-CSF and genetically engineered variance of G-CSF may be the expression products of genetically engineered prokaryotic or eukaryotic host cells.
Compositions et procédés de traitement ou de prévention d'infections chez les animaux canins ou félins, consistant à administrer une dose efficace de facteur de croissance des colonies de granulocytes (FCCG). Le FCCG peut être dérivé naturellement, ou selon un autre mode de réalisation, le FCCG ainsi que des variantes de celui-ci mises au point génétiquement peuvent être les produits d'expression de cellules hôtes procaryotiques ou eucaryotiques mises au point génétiquement.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES USING MICROORGANISMS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1991</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIh29vcN8A_2DPH09wtWcPRzUfB1DfHwdwlWcPMPUggJcnUM8fRzVwCyA4Jcw1z9wDxPPzdXZ4gOTz8FZ0c_Tz9XsF43Vx8I09PX0SeYh4E1LTGnOJUXSnMzABWEOHvophbkx6cWFyQmp-allsSH-1saGpiaW1o4GhoToQQAMQMx0g</recordid><startdate>19910502</startdate><enddate>19910502</enddate><creator>BOONE, THOMAS, C</creator><creator>MILLER, ALLAN, L</creator><scope>EVB</scope></search><sort><creationdate>19910502</creationdate><title>COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFECTIONS IN CANINE AND FELINE ANIMALS</title><author>BOONE, THOMAS, C ; MILLER, ALLAN, L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO9105798A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1991</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES USING MICROORGANISMS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BOONE, THOMAS, C</creatorcontrib><creatorcontrib>MILLER, ALLAN, L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BOONE, THOMAS, C</au><au>MILLER, ALLAN, L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFECTIONS IN CANINE AND FELINE ANIMALS</title><date>1991-05-02</date><risdate>1991</risdate><abstract>Compositions and methods for treating or preventing infections in canine or feline animals which comprises administering an effective amount of granulocyte colony stimulating factor (G-CSF), are disclosed. The G-CSF may be naturally derived, or alternatively, the G-CSF and genetically engineered variance of G-CSF may be the expression products of genetically engineered prokaryotic or eukaryotic host cells.
Compositions et procédés de traitement ou de prévention d'infections chez les animaux canins ou félins, consistant à administrer une dose efficace de facteur de croissance des colonies de granulocytes (FCCG). Le FCCG peut être dérivé naturellement, ou selon un autre mode de réalisation, le FCCG ainsi que des variantes de celui-ci mises au point génétiquement peuvent être les produits d'expression de cellules hôtes procaryotiques ou eucaryotiques mises au point génétiquement.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_WO9105798A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIREDCHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERSFROM A RACEMIC MIXTURE HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES USING MICROORGANISMS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| title | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INFECTIONS IN CANINE AND FELINE ANIMALS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T23%3A00%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BOONE,%20THOMAS,%20C&rft.date=1991-05-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO9105798A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |